New data reinforce daratumumab as standard of care for multiple myeloma
Long-term survival projections suggest improved outcomes for patients
Read MoreLong-term survival projections suggest improved outcomes for patients
Read MoreStudies show improved bone mineral density and healthcare cost reductions
Read MoreMajor update aims to accelerate research and strengthen patient safety
Read MoreBirmingham researchers to make MGUS monitoring more efficient
Read MoreResearch targets lysosomal function restoration for neurodegeneration
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479